hig.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard-cite-them-right
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • sv-SE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • de-DE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Evaluatin Strategy for Candidates drug and implementation to product D: MBA-thesis in marketing
University of Gävle, Department of Business Administration and Economics.
2008 (English)Independent thesis Advanced level (degree of Magister), 10 points / 15 hpStudent thesis
Abstract [en]

Biovitrumis is one of the larger biopharma companies in Euprope and conducts research in different niche areas. One of the interested areas for Biovitrum is Exocrine Pancreatic insufficiency. Biovitrum has a candidate drug (product D) in early development process for treatment of. Exocrine Pancreatic Insufficiency.

The Drug development is a long, complicated and costly process. Therefore, it is very important for managers to know the commercial value of a future drug. The purpose of this report is to develop a model for evaluation of candidate drug in early development phase and analysis of market potential for product D for treatment of Chronic pancreatitis. Chronic pancreatitis is disease within sub group of Exocrine Pancreatic Insufficiency.

The deductive reasoning approach and quantitative data is used in this report. Only secondary data is collected for this study. The sources of secondary data are research papers, Google Pub-Med database and consultant companies.

A new model is developed for evaluation of candidate drug .This model can analyse the market potential, unmet medical need, and calculate net present values. This study shows that there is unmet medical need in chronic pancreatitis. The result also shows that product D has comparative advantages over present products in the market and future competitors. The product D can full fill the unmet medical need for treatment of Chronic pancreatitis

Place, publisher, year, edition, pages
2008. , p. 45
Keywords [en]
Candidate Drug, Evaluation strategy, market analysis
National Category
Business Administration
Identifiers
URN: urn:nbn:se:hig:diva-694Archive number: E3BA: DiVA 082/08OAI: oai:DiVA.org:hig-694DiVA, id: diva2:120278
Uppsok
samhälle/juridik
Supervisors
Examiners
Available from: 2008-09-16 Created: 2008-09-16

Open Access in DiVA

fulltext(896 kB)1240 downloads
File information
File name FULLTEXT01.pdfFile size 896 kBChecksum MD5
f03612459bc7c76905232ef3e2c494b22e33f097325e17bad25986558ed093b74d9b3bb4
Type fulltextMimetype application/pdf

By organisation
Department of Business Administration and Economics
Business Administration

Search outside of DiVA

GoogleGoogle Scholar
Total: 1240 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 667 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard-cite-them-right
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • sv-SE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • de-DE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf